Latest Articles
New Trends of Endometrial Cancer Market To Receive Overwhelming - openPR
New Trends of Endometrial Cancer Market To Receive Overwhelming openPR
Published: Nov. 5, 2024, 2:36 p.m.
Role of HOXA10 in pathologies of the endometrium.
HOXA10 belongs to the homeobox gene family and is essential for uterine biogenesis, endometrial receptivity, embryo implantation, and stromal cell decidualization. Available evidence suggests that the expression of HOXA10 is …
Published: Nov. 5, 2024, midnight
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer - OncLive
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer OncLive
Published: Nov. 4, 2024, 8:08 p.m.
NEDD4 Knockdown Suppresses Human Endometrial Stromal Cell Growth and Invasion by Regulating PTGS2-Mediated Ferroptosis in Endometriosis.
Endometriosis (EM) is a gynecological disease characterized by the benign growth of endometrial tissue outside the uterus. Upregulation of neuronally expressed developmentally downregulated 4 (NEDD4) has been reported to accelerate …
Published: Nov. 4, 2024, midnight
Morning Extra: Endometrial Cancer Survivor - PHL17 Philadelphia
Morning Extra: Endometrial Cancer Survivor PHL17 Philadelphia
Published: Oct. 31, 2024, 2:53 p.m.
Beating the Odds: Hampton Bays Woman Defeats Aggressive Endometrial Cancer - 27east.com
Beating the Odds: Hampton Bays Woman Defeats Aggressive Endometrial Cancer 27east.com
Published: Oct. 30, 2024, 6:23 p.m.
MMR Status Doesn’t Impact Outcomes of Chemo in Endometrial Cancer - Cancer Therapy Advisor
MMR Status Doesn’t Impact Outcomes of Chemo in Endometrial Cancer Cancer Therapy Advisor
Published: Oct. 29, 2024, 2:30 p.m.
Can Pembrolizumab Improve dMMR Endometrial Cancer Outcomes? - Medscape
Can Pembrolizumab Improve dMMR Endometrial Cancer Outcomes? Medscape
Published: Oct. 28, 2024, 1:14 p.m.
Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis - Frontiers
Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis Frontiers
Published: Oct. 28, 2024, 10:28 a.m.
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report - Cureus
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report Cureus
Published: Oct. 27, 2024, 7:49 a.m.
Link copied to clipboard!